Attached files

file filename
EX-99.1 - PRESS RELEASE DATED FEBRUARY 25, 2013 - ST JUDE MEDICAL, LLCstjude130839_ex99-1.htm

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  February 25, 2013

 

 

ST. JUDE MEDICAL, INC.

(Exact name of registrant as specified in its charter)

 

Minnesota 1-12441 41-1276891
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
     
One St. Jude Medical Drive, St. Paul, MN   55117
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code:  (651) 756-2000

 

Not applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 
 

 

Item 8.01  Other Events.

 

On February 25, 2013, St. Jude Medical, Inc. issued a press release announcing its quarterly dividend, a copy of which is attached hereto as Exhibit 99.1. The press released identified a record date of March 29, 2013 for this dividend. Since the New York Stock Exchange (“NYSE”) is closed for trading on such date, however, the effective record date for this dividend will be March 28, 2013.

 

Item 9.01 Financial Statements and Exhibits.

 

(d)  Exhibits:

 

  99.1        Press release issued by St. Jude Medical, Inc. on February 25, 2013.

 

 

 

 

 

 

 

 

 

 

 
 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

  ST. JUDE MEDICAL, INC.
     
     
     
Date:  February 25, 2013 By: /s/ Jason Zellers
    Jason Zellers
Vice President, General Counsel
and Corporate Secretary

 

 

 

 

 

 

 

 

 

 

 

 
 

 

EXHIBIT INDEX

  

 

   Exhibit No.    Description of Exhibit
   
99.1 Press release issued by St. Jude Medical, Inc. on February 25, 2013.